lecanemab: Clinical Trials

4 completed. 4 Phase 1.

By phase and status

Phase	Trials	Status
Phase 1	4	Completed 4

Follow lecanemab: new trials by email Literature Review of lecanemab trials Research Report on lecanemab

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants Lecanemab - Healthy Volunteers	Phase 1	Completed	Eisai Inc.	160	2022-09-06	2023-01-18
A Study of Subcutaneous Lecanemab in Healthy Participants Lecanemab - Healthy Volunteers	Phase 1	Completed	Eisai Inc.	60	2021-09-07	2022-01-19
A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease BAN2401 2.5 mg/kg, BAN2401 5 mg/kg, BAN2401 10 mg/kg - Alzheimer's Disease	Phase 1	Completed	Eisai Co., Ltd.	26	2013-09-01	2015-06-08
A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study Active Comparator: A, Placebo Comparator B, Active Comparator B - Alzheimer's Disease	Phase 1	Completed	Eisai Inc.	80	2010-08-01	2020-11-23

Conditions studied

Alzheimer Disease (2)  ·  Cognitive Dysfunction (1)

Sponsors

Eisai Inc. (3)  ·  Eisai Co., Ltd. (1)

Countries

United States (3)  ·  Japan (1)

Results publications

PMID 27048170